Nifty
:
13967.50
Sensex
:
47409.93
-271.40 (-1.91%)
-937.66 (-1.94%)
Nifty
Sensex
:
:
13967.50
47409.93
-271.40 (-1.91%)
-937.66 (-1.94%)

Hospital & Healthcare Services

Rating :
63/99  (View)

BSE: 508869 | NSE: APOLLOHOSP

NSE BSE
2600.40
-86.50 (-3.22%)
27-Jan-2021 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  2698.00
  •  2749.65
  •  2587.25
  •  2686.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1665899
  •  43320.04
  •  2749.65
  •  1047.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 38,637.09
  • 236.18
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 41,765.89
  • 0.22%
  • 11.95

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 30.82%
  • 0.31%
  • 4.47%
  • FII
  • DII
  • Others
  • 51.7%
  • 10.92%
  • 1.78%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.75
  • 12.60
  • 10.91

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.20
  • 18.37
  • 14.79

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.06
  • 16.97
  • 57.52

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 56.97
  • 74.00
  • 88.19

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.47
  • 5.68
  • 6.08

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 23.25
  • 23.10
  • 21.82

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
2,760.72
2,840.74
-2.82%
2,171.50
2,571.89
-15.57%
2,922.43
2,499.50
16.92%
2,911.74
2,495.04
16.70%
Expenses
2,460.89
2,427.26
1.39%
2,136.02
2,208.17
-3.27%
2,542.36
2,219.93
14.52%
2,481.72
2,215.93
11.99%
EBITDA
299.83
413.48
-27.49%
35.48
363.72
-90.25%
380.07
279.57
35.95%
430.02
279.11
54.07%
EBIDTM
10.86%
14.56%
1.63%
14.14%
13.01%
11.19%
14.77%
11.19%
Other Income
11.32
3.50
223.43%
7.72
9.86
-21.70%
3.95
11.76
-66.41%
9.66
12.49
-22.66%
Interest
122.30
134.34
-8.96%
127.39
125.77
1.29%
135.23
85.42
58.31%
137.43
84.44
62.75%
Depreciation
149.45
154.51
-3.27%
160.18
144.01
11.23%
163.86
104.90
56.21%
157.31
98.42
59.84%
PBT
74.84
128.13
-41.59%
-244.37
103.80
-
283.23
101.01
180.40%
144.94
108.74
33.29%
Tax
6.60
50.55
-86.94%
-40.76
45.25
-
74.04
39.10
89.36%
55.35
53.14
4.16%
PAT
68.24
77.58
-12.04%
-203.61
58.55
-
209.19
61.91
237.89%
89.59
55.60
61.13%
PATM
2.47%
2.73%
-9.38%
2.28%
7.16%
2.48%
3.08%
2.23%
EPS
4.33
6.20
-30.16%
-14.96
4.11
-
15.77
5.87
168.65%
6.62
4.10
61.46%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
10,766.39
11,246.80
9,617.40
8,243.47
7,255.70
6,214.65
5,178.45
4,384.22
3,768.71
3,147.53
2,605.35
Net Sales Growth
3.45%
16.94%
16.67%
13.61%
16.75%
20.01%
18.12%
16.33%
19.74%
20.81%
 
Cost Of Goods Sold
5,610.86
5,498.90
4,660.90
4,032.66
3,598.88
3,054.74
2,581.20
2,150.13
1,855.83
1,562.33
1,314.86
Gross Profit
5,155.53
5,747.90
4,956.50
4,210.81
3,656.83
3,159.91
2,597.26
2,234.09
1,912.87
1,585.20
1,290.49
GP Margin
47.89%
51.11%
51.54%
51.08%
50.40%
50.85%
50.16%
50.96%
50.76%
50.36%
49.53%
Total Expenditure
9,620.99
9,665.90
8,554.70
7,450.29
6,548.95
5,534.38
4,443.78
3,711.81
3,160.51
2,634.41
2,186.49
Power & Fuel Cost
-
213.00
183.80
166.68
127.89
122.80
93.98
85.33
69.93
54.87
47.39
% Of Sales
-
1.89%
1.91%
2.02%
1.76%
1.98%
1.81%
1.95%
1.86%
1.74%
1.82%
Employee Cost
-
1,852.90
1,598.20
1,404.39
1,196.50
1,023.55
860.02
727.45
623.13
502.86
415.12
% Of Sales
-
16.47%
16.62%
17.04%
16.49%
16.47%
16.61%
16.59%
16.53%
15.98%
15.93%
Manufacturing Exp.
-
519.00
419.80
453.39
430.28
393.04
246.61
200.01
157.83
136.68
112.21
% Of Sales
-
4.61%
4.37%
5.50%
5.93%
6.32%
4.76%
4.56%
4.19%
4.34%
4.31%
General & Admin Exp.
-
1,444.60
1,551.20
1,271.85
1,100.53
862.57
612.33
516.37
423.11
350.29
277.89
% Of Sales
-
12.84%
16.13%
15.43%
15.17%
13.88%
11.82%
11.78%
11.23%
11.13%
10.67%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
137.50
140.80
121.32
94.88
77.67
49.63
32.52
30.67
27.38
0.00
% Of Sales
-
1.22%
1.46%
1.47%
1.31%
1.25%
0.96%
0.74%
0.81%
0.87%
0.73%
EBITDA
1,145.40
1,580.90
1,062.70
793.18
706.75
680.27
734.67
672.41
608.20
513.12
418.86
EBITDA Margin
10.64%
14.06%
11.05%
9.62%
9.74%
10.95%
14.19%
15.34%
16.14%
16.30%
16.08%
Other Income
32.65
33.10
32.40
32.15
44.33
52.54
36.75
21.46
30.17
25.91
15.05
Interest
522.35
532.80
327.00
295.07
257.35
180.02
117.85
119.38
103.25
89.14
77.85
Depreciation
630.80
619.70
395.50
359.03
314.04
263.83
211.65
167.79
142.34
123.91
94.75
PBT
258.64
461.50
372.60
171.24
179.69
288.95
441.92
406.71
392.78
325.97
261.32
Tax
95.23
225.10
173.40
111.91
90.96
96.90
130.00
101.76
105.04
114.96
87.30
Tax Rate
36.82%
34.11%
46.54%
65.35%
50.62%
31.78%
28.55%
25.02%
26.32%
35.27%
33.41%
PAT
163.41
458.00
235.00
117.19
178.60
209.14
330.55
306.31
295.70
212.24
175.54
PAT before Minority Interest
194.70
434.90
199.20
59.33
88.73
207.99
325.41
304.94
294.04
211.01
174.02
Minority Interest
31.29
23.10
35.80
57.86
89.87
1.15
5.14
1.37
1.66
1.23
1.52
PAT Margin
1.52%
4.07%
2.44%
1.42%
2.46%
3.37%
6.38%
6.99%
7.85%
6.74%
6.74%
PAT Growth
-35.57%
94.89%
100.53%
-34.38%
-14.60%
-36.73%
7.91%
3.59%
39.32%
20.91%
 
Unadjusted EPS
11.76
32.95
16.91
8.43
12.85
15.05
23.78
22.04
21.27
15.27
12.63

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
3,339.10
3,333.50
3,251.51
3,313.20
3,331.13
3,171.33
2,976.68
2,746.77
2,506.82
1,898.94
Share Capital
69.60
69.60
69.56
73.01
69.56
69.56
69.56
69.56
67.23
62.35
Total Reserves
3,266.50
3,261.10
3,180.05
3,238.91
3,260.64
3,100.63
2,907.12
2,677.21
2,400.88
1,768.08
Non-Current Liabilities
6,482.80
4,613.00
4,423.17
4,398.65
2,700.91
2,138.49
1,557.42
1,315.77
736.78
1,045.99
Secured Loans
2,852.00
2,868.70
2,728.43
2,477.64
2,303.08
1,563.22
1,050.25
1,057.48
514.29
650.49
Unsecured Loans
0.00
83.40
195.37
475.74
146.70
164.83
172.13
21.41
60.08
97.51
Long Term Provisions
1,011.20
883.00
784.96
701.39
3.27
3.45
2.20
2.79
2.17
208.06
Current Liabilities
2,337.30
1,955.40
1,567.23
963.36
1,249.83
1,076.33
796.77
734.03
726.44
632.56
Trade Payables
908.80
713.10
606.02
501.19
550.19
419.14
280.37
221.76
190.33
192.25
Other Current Liabilities
807.80
640.80
501.70
295.59
446.16
439.91
320.99
336.90
282.93
228.20
Short Term Borrowings
497.50
498.20
379.17
70.69
182.93
85.74
62.50
57.88
174.99
142.73
Short Term Provisions
123.20
103.30
80.33
95.89
70.55
131.54
132.92
117.49
78.19
69.38
Total Liabilities
12,289.90
10,037.40
9,374.35
8,799.79
7,359.80
6,459.16
5,349.65
4,813.91
3,982.60
3,602.37
Net Block
7,426.20
4,975.10
4,765.71
4,583.29
3,997.42
3,244.12
2,681.29
2,340.59
2,011.25
1,529.51
Gross Block
10,222.00
6,599.50
6,023.63
5,499.02
4,609.14
4,285.44
3,570.60
3,096.80
2,640.88
2,047.83
Accumulated Depreciation
2,795.80
1,624.40
1,257.92
915.73
611.73
1,041.32
889.31
756.22
625.76
514.46
Non Current Assets
9,643.00
7,755.60
7,154.22
6,670.57
5,385.23
4,520.29
3,848.77
3,260.51
2,920.16
2,723.60
Capital Work in Progress
235.60
821.80
712.20
346.86
561.56
532.64
491.31
403.39
209.27
361.00
Non Current Investment
365.10
399.30
301.26
307.96
270.65
165.08
166.07
147.95
442.17
386.14
Long Term Loans & Adv.
1,598.40
1,431.60
1,254.62
1,325.53
498.28
578.45
510.11
368.57
248.89
443.86
Other Non Current Assets
17.70
127.80
120.43
106.93
57.33
0.00
0.00
0.00
8.57
3.09
Current Assets
2,646.90
2,281.80
2,220.13
2,129.22
1,974.57
1,938.88
1,500.89
1,553.41
1,062.44
878.77
Current Investments
74.90
68.80
57.87
105.84
81.73
145.57
155.50
378.76
121.98
115.86
Inventories
737.70
584.70
565.84
466.87
406.13
350.26
278.55
218.68
191.54
158.44
Sundry Debtors
1,027.20
1,023.20
825.19
750.53
609.37
609.27
519.77
473.30
386.73
300.31
Cash & Bank
466.80
346.90
417.25
524.50
378.79
377.33
274.15
320.06
236.84
178.12
Other Current Assets
340.30
178.80
241.68
58.44
498.55
456.43
272.93
162.60
125.35
126.04
Short Term Loans & Adv.
96.70
79.40
112.29
223.03
437.25
419.99
240.72
138.97
98.44
98.84
Net Current Assets
309.60
326.40
652.90
1,165.86
724.74
862.55
704.12
819.37
336.00
246.21
Total Assets
12,289.90
10,037.40
9,374.35
8,799.79
7,359.80
6,459.17
5,349.66
4,813.92
3,982.60
3,602.37

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
1,292.80
905.20
536.96
622.55
597.17
469.95
373.39
442.75
387.05
258.83
PBT
656.90
373.60
59.56
131.12
305.25
455.41
406.71
399.08
325.97
261.32
Adjustment
1,012.40
770.10
807.85
703.53
425.00
274.83
289.98
226.59
210.32
168.93
Changes in Working Capital
-70.40
-46.00
-205.35
-78.48
10.82
-160.83
-214.04
-90.08
-87.29
-104.22
Cash after chg. in Working capital
1,598.90
1,097.70
662.06
756.17
741.07
569.42
482.64
535.58
449.00
326.03
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-306.10
-192.50
-125.10
-133.62
-141.19
-100.28
-110.38
-92.74
-62.72
-67.51
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
-2.71
0.81
1.12
-0.09
0.77
0.31
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-288.80
-710.60
-404.91
-1,151.88
-888.21
-759.07
-355.83
-732.52
-467.96
-441.46
Net Fixed Assets
-2,378.60
-622.09
-796.57
-582.72
-278.38
-570.07
-501.10
-523.07
-322.80
-267.98
Net Investments
9.00
-185.02
163.48
-186.58
-164.16
-22.99
206.00
-131.91
-140.01
-134.32
Others
2,080.80
96.51
228.18
-382.58
-445.67
-166.01
-60.73
-77.54
-5.15
-39.16
Cash from Financing Activity
-909.50
-214.70
-108.50
476.95
329.93
392.31
-63.48
372.99
135.40
46.74
Net Cash Inflow / Outflow
94.50
-20.10
23.55
-52.37
38.89
103.19
-45.92
83.23
54.49
-135.89
Opening Cash & Equivalents
286.20
306.30
282.78
335.15
339.90
274.15
320.06
236.84
182.35
314.01
Closing Cash & Equivalent
380.70
286.20
306.33
282.78
378.79
377.33
274.15
320.06
236.84
178.12

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
239.10
238.71
233.02
237.25
238.81
227.87
213.96
197.43
183.55
146.78
ROA
3.90%
2.05%
0.65%
1.10%
3.01%
5.51%
6.00%
6.69%
5.56%
5.09%
ROE
13.08%
6.07%
1.81%
2.68%
6.41%
10.59%
10.66%
11.28%
9.82%
9.99%
ROCE
17.13%
10.24%
7.12%
6.94%
8.57%
12.09%
12.71%
13.79%
13.43%
12.51%
Fixed Asset Turnover
1.34
1.52
1.43
1.44
1.40
1.32
1.32
1.31
1.34
1.37
Receivable days
33.27
35.08
34.88
34.21
35.79
39.79
41.34
41.65
39.84
36.65
Inventory Days
21.46
21.83
22.86
21.96
22.21
22.16
20.70
19.86
20.29
20.99
Payable days
33.94
33.10
31.43
33.78
36.33
31.87
27.43
26.31
29.25
35.67
Cash Conversion Cycle
20.78
23.81
26.32
22.38
21.67
30.08
34.61
35.20
30.88
21.97
Total Debt/Equity
1.08
1.10
1.06
0.95
0.85
0.63
0.45
0.44
0.33
0.52
Interest Cover
2.24
2.14
1.58
1.70
2.69
4.86
4.41
4.87
4.66
4.36

Annual Reports:

News Update


  • Apollo Hospitals raises Rs 1170 crore via QIBs
    25th Jan 2021, 09:11 AM

    Pursuant to the allotment of equity shares in the issue, the paid-up equity share capital of the company stands increased from Rs 69,56,25,795 consisting of 13,91,25,159 equity shares

    Read More
  • Apollo Hospitals group launches North India's first state-of-the-art IVF Centre in Noida
    5th Jan 2021, 12:36 PM

    Apollo Fertility centres, following the mission of Apollo Hospitals, aim to bring fertility treatment of international standards within the reach of every individual

    Read More
  • Apollo Hospitals gearing up to give one million vaccines a day
    26th Nov 2020, 13:59 PM

    Apollo 24/7 is doing a survey asking customers whether they will take the vaccine and also making them register

    Read More
  • Apollo Hospitals Group collaborates with Tata Medical and Diagnostics
    20th Nov 2020, 09:30 AM

    The collaboration aims to introduce 'TataMD CHECK' diagnostic test for COVID-19 in the country

    Read More
  • Apollo Hospitals reports 30% fall in Q2 consolidated net profit
    12th Nov 2020, 12:07 PM

    Total consolidated income of the company decreased by 2.54% at Rs 2772.04 crore for Q2FY21

    Read More
  • Apollo Hospital Ent. - Quarterly Results
    11th Nov 2020, 19:17 PM

    Read More
  • Apollo Hospitals enters into partnership with India Medtronic
    30th Oct 2020, 13:00 PM

    Medtronic will help in bringing in stroke technologies, technical expertise, training and comprehensive stroke management with the integration of AI platform at the Apollo Institute of Neurosciences

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.